PHENOBARBITAL SODIUM

PHENOBARBITAL SODIUM was reported 416 times

PHENOBARBITAL SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTICONVULSANT DRUG LEVEL THERAPEUTIC 3 0.3750
1 NATURAL KILLER CELL ACTIVITY ABNORMAL 1 0.1667
2 NEW ONSET REFRACTORY STATUS EPILEPTICUS 11 0.1000
3 NEONATAL OVERSEDATION 2 0.0741
4 POSTHAEMORRHAGIC HYDROCEPHALUS 4 0.0690
5 DOUBLE INLET LEFT VENTRICLE 1 0.0526
6 SELENIUM DEFICIENCY 2 0.0476
7 MECONIUM ILEUS 3 0.0455
8 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 1 0.0323
9 MACROPHAGE ACTIVATION 1 0.0294
10 XANTHOCHROMIA 1 0.0278
11 SENSORY PROCESSING SENSITIVITY 1 0.0227
12 LEUKAEMIC INFILTRATION PULMONARY 1 0.0217
13 CORTICAL VISUAL IMPAIRMENT 1 0.0172
14 THROAT LESION 11 0.0161
15 INTRACRANIAL INFECTION 2 0.0160
16 OVARIAN FIBROMA 1 0.0156
17 PURPLE GLOVE SYNDROME 2 0.0153
18 ALCOHOLIC SEIZURE 1 0.0135
19 EAR INFECTION VIRAL 2 0.0125
20 ZINC DEFICIENCY 2 0.0093
21 IIIRD NERVE DISORDER 1 0.0070
22 BRUCELLOSIS 1 0.0066
23 NEUROSYPHILIS 1 0.0066
24 NEONATAL BEHAVIOURAL SYNDROME 2 0.0065
25 NECROSIS ISCHAEMIC 3 0.0065
26 PROTEIN DEFICIENCY 2 0.0064
27 GASTROENTERITIS ADENOVIRUS 1 0.0064
28 GASTROENTERITIS EOSINOPHILIC 2 0.0059
29 GENITALIA EXTERNAL AMBIGUOUS 1 0.0058
30 CHRONIC RESPIRATORY DISEASE 2 0.0057
31 EXAGGERATED STARTLE RESPONSE 1 0.0055
32 RETINOPATHY OF PREMATURITY 3 0.0054
33 HAEMOFILTRATION 1 0.0053
34 HERPES SIMPLEX TEST POSITIVE 1 0.0050
35 VESICOURETERIC REFLUX 2 0.0049
36 ABNORMAL CLOTTING FACTOR 1 0.0049
37 POSTICTAL STATE 5 0.0048
38 RENAL VESSEL DISORDER 1 0.0047
39 OCULOMUCOCUTANEOUS SYNDROME 2 0.0047
40 MULTIPLE-DRUG RESISTANCE 13 0.0042
41 BRONCHOPULMONARY DYSPLASIA 3 0.0037
42 SCLERAL DISORDER 1 0.0037
43 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
44 INCISION SITE PAIN 4 0.0034
45 GASTRIC HYPOMOTILITY 1 0.0033
46 EPIDERMOLYSIS BULLOSA 1 0.0032
47 MUCOSAL ULCERATION 3 0.0030
48 HEART INJURY 7 0.0028
49 OTITIS MEDIA ACUTE 2 0.0027
50 ENTEROBACTER SEPSIS 1 0.0027
51 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
52 INHIBITORY DRUG INTERACTION 4 0.0025
53 PERSISTENT DEPRESSIVE DISORDER 1 0.0025
54 INFANTILE APNOEA 2 0.0025
55 OESOPHAGEAL DISORDER 9 0.0023
56 GLIOSIS 1 0.0023
57 TEMPORAL LOBE EPILEPSY 1 0.0023
58 FACIAL NERVE DISORDER 1 0.0023
59 FEEDING INTOLERANCE 1 0.0022
60 MUSCLE MASS 1 0.0022
61 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
62 POSTOPERATIVE INFECTION 1 0.0021
63 RED BLOOD CELLS URINE POSITIVE 2 0.0021
64 BLOOD URIC ACID DECREASED 1 0.0021
65 TONGUE DISCOLOURATION 9 0.0021
66 ROOT CANAL INFECTION 1 0.0020
67 EAR INJURY 1 0.0020
68 SUPERINFECTION 3 0.0020
69 CATARACT OPERATION COMPLICATION 1 0.0020
70 TRACHEAL DISORDER 1 0.0019
71 CONVULSION NEONATAL 1 0.0019
72 ANAL STENOSIS 1 0.0019
73 STATUS EPILEPTICUS 21 0.0019
74 CRYSTALLURIA 1 0.0018
75 PRESBYOPIA 1 0.0018
76 BRAIN SCAN ABNORMAL 1 0.0018
77 FOCAL DYSCOGNITIVE SEIZURES 2 0.0018
78 ENTERAL NUTRITION 1 0.0017
79 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 2 0.0017
80 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
81 PROTHROMBIN TIME RATIO DECREASED 1 0.0016
82 NECROTISING COLITIS 2 0.0016
83 CHANGE IN SEIZURE PRESENTATION 1 0.0015
84 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 1 0.0015
85 PAROTID GLAND ENLARGEMENT 1 0.0015
86 TRIPLE NEGATIVE BREAST CANCER 1 0.0015
87 PARANEOPLASTIC SYNDROME 1 0.0015
88 NEURODEVELOPMENTAL DISORDER 1 0.0015
89 WALKING DISABILITY 3 0.0014
90 TONIC CONVULSION 2 0.0014
91 FOETAL EXPOSURE TIMING UNSPECIFIED 1 0.0014
92 INFANTILE SPASMS 1 0.0014
93 APALLIC SYNDROME 1 0.0014
94 ESCHAR 1 0.0014
95 CEREBELLAR SYNDROME 3 0.0014
96 BRAIN CONTUSION 1 0.0014
97 BLISTER RUPTURE 1 0.0013
98 HYPERTHERMIA MALIGNANT 2 0.0013
99 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
100 MYOCLONIC EPILEPSY 2 0.0013
101 PULMONARY MYCOSIS 1 0.0013
102 OPHTHALMOPLEGIA 2 0.0013
103 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0012
104 ANTICONVULSANT DRUG LEVEL INCREASED 2 0.0012
105 SEIZURE CLUSTER 1 0.0012
106 MYOCARDIAL FIBROSIS 1 0.0012
107 HEPATIC HAEMORRHAGE 1 0.0012
108 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
109 TESTICULAR ATROPHY 1 0.0011
110 NYSTAGMUS 6 0.0011
111 DRUG DETOXIFICATION 1 0.0011
112 PSYCHOGENIC SEIZURE 1 0.0011
113 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
114 PETIT MAL EPILEPSY 5 0.0010
115 PARTIAL SEIZURES 5 0.0010
116 HYPOPERFUSION 1 0.0010
117 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
118 LANGUAGE DISORDER 2 0.0009
119 EPILEPSY 27 0.0009
120 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
121 BILIRUBIN CONJUGATED INCREASED 2 0.0009
122 PNEUMONIA INFLUENZAL 1 0.0008
123 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
124 KIDNEY TRANSPLANT REJECTION 4 0.0008
125 CARDIAC DEATH 1 0.0008
126 FEBRILE CONVULSION 1 0.0008
127 HAEMATOCRIT ABNORMAL 1 0.0008
128 ORAL MUCOSA EROSION 1 0.0008
129 NEUTROPHIL COUNT INCREASED 8 0.0008
130 BILIARY TRACT DISORDER 1 0.0007
131 AUDITORY DISORDER 1 0.0007
132 CEREBELLAR HAEMORRHAGE 1 0.0007
133 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
134 APRAXIA 1 0.0007
135 METABOLIC ENCEPHALOPATHY 2 0.0007
136 PALLOR 18 0.0007
137 CALCULUS URINARY 1 0.0006
138 RESUSCITATION 1 0.0006
139 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
140 HYPERAMMONAEMIA 3 0.0006
141 HEPATORENAL SYNDROME 1 0.0006
142 SEIZURE 68 0.0006
143 DRUG RESISTANCE 15 0.0006
144 GRANULOMA 2 0.0006
145 THYROIDECTOMY 1 0.0006
146 HYPERAMMONAEMIC ENCEPHALOPATHY 1 0.0006
147 HYPERREFLEXIA 2 0.0006
148 BLOOD LACTIC ACID INCREASED 3 0.0006
149 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
150 PRODUCT CONTAMINATION 2 0.0006
151 INTESTINAL ISCHAEMIA 3 0.0005
152 PUPILLARY REFLEX IMPAIRED 1 0.0005
153 NASAL OBSTRUCTION 1 0.0005
154 CLEFT PALATE 1 0.0005
155 TRAUMATIC LUNG INJURY 1 0.0005
156 BICYTOPENIA 1 0.0005
157 PYELONEPHRITIS ACUTE 1 0.0005
158 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
159 GENE MUTATION 1 0.0005
160 GASTROINTESTINAL PERFORATION 2 0.0005
161 HYPERPYREXIA 2 0.0005
162 OCULOGYRIC CRISIS 1 0.0005
163 HEPATIC LESION 2 0.0005
164 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
165 CHRONIC GASTRITIS 1 0.0004
166 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
167 MYOPIA 1 0.0004
168 MYOCLONUS 5 0.0004
169 HYPOTONIA 4 0.0004
170 DERMATITIS EXFOLIATIVE 2 0.0004
171 LYMPHOCYTE COUNT DECREASED 7 0.0004
172 HEPATOSPLENOMEGALY 1 0.0004
173 PULMONARY HAEMORRHAGE 3 0.0004
174 HEPATIC FUNCTION ABNORMAL 14 0.0004
175 ALCOHOL POISONING 1 0.0004
176 BEHAVIOUR DISORDER 2 0.0004
177 CLONUS 1 0.0004
178 ORAL FUNGAL INFECTION 1 0.0004
179 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
180 RESPIRATORY SYMPTOM 1 0.0004
181 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
182 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
183 COMA SCALE ABNORMAL 1 0.0003
184 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
185 COLD SWEAT 6 0.0003
186 ATAXIA 4 0.0003
187 URINE ANALYSIS ABNORMAL 1 0.0003
188 LUNG ADENOCARCINOMA 1 0.0003
189 ERYTHEMA MULTIFORME 3 0.0003
190 SWOLLEN TONGUE 10 0.0003
191 STEVENS-JOHNSON SYNDROME 7 0.0003
192 PANCREATITIS ACUTE 7 0.0003
193 SKIN EROSION 1 0.0003
194 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
195 POLYP 2 0.0003
196 COLITIS ISCHAEMIC 2 0.0003
197 DRUG LEVEL DECREASED 3 0.0003
198 DUODENAL ULCER 2 0.0003
199 DRUG ERUPTION 5 0.0003
200 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
201 THROMBOCYTOSIS 1 0.0003
202 UNRESPONSIVE TO STIMULI 7 0.0003
203 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
204 HYPERTHERMIA 2 0.0003
205 COMMUNICATION DISORDER 1 0.0003
206 GASTRIC INFECTION 1 0.0003
207 BACTERAEMIA 3 0.0003
208 PNEUMOTHORAX 4 0.0003
209 HYPERLIPIDAEMIA 3 0.0003
210 CEREBRAL ATROPHY 1 0.0003
211 RESPIRATORY DEPRESSION 3 0.0002
212 HYPERURICAEMIA 1 0.0002
213 ILEUS 3 0.0002
214 COAGULOPATHY 4 0.0002
215 DERMATITIS ALLERGIC 3 0.0002
216 HAEMODIALYSIS 2 0.0002
217 POOR PERIPHERAL CIRCULATION 1 0.0002
218 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
219 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
220 URINE OUTPUT DECREASED 2 0.0002
221 BLOOD CREATINE INCREASED 1 0.0002
222 WHEELCHAIR USER 1 0.0002
223 ILEUS PARALYTIC 1 0.0002
224 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
225 HYPOVOLAEMIC SHOCK 1 0.0002
226 THROMBOTIC MICROANGIOPATHY 2 0.0002
227 STAPHYLOCOCCAL SEPSIS 1 0.0002
228 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
229 HYPERNATRAEMIA 1 0.0002
230 PROTEIN URINE PRESENT 1 0.0002
231 PATHOLOGICAL FRACTURE 1 0.0002
232 SUBARACHNOID HAEMORRHAGE 2 0.0002
233 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
234 RESPIRATORY FAILURE 14 0.0002
235 SERUM FERRITIN INCREASED 1 0.0002
236 HALLUCINATION, VISUAL 4 0.0002
237 ANAL FISTULA 1 0.0002
238 BRUXISM 1 0.0002
239 GINGIVITIS 1 0.0002
240 HIP SURGERY 1 0.0002
241 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
242 CYTOMEGALOVIRUS INFECTION 3 0.0002
243 GASTRIC ULCER HAEMORRHAGE 1 0.0002
244 LIVER DISORDER 8 0.0002
245 GRANULOCYTOPENIA 1 0.0002
246 GASTRIC HAEMORRHAGE 2 0.0002
247 ELECTROLYTE IMBALANCE 2 0.0002
248 HYPERTRIGLYCERIDAEMIA 1 0.0002
249 HYPERCHLORHYDRIA 1 0.0002
250 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
251 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
252 PLEURISY 1 0.0002
253 LEUKOCYTOSIS 3 0.0002
254 INGUINAL HERNIA 1 0.0002
255 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
256 SEPSIS 18 0.0002
257 PRODUCT COMPLAINT 4 0.0002
258 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
259 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
260 HAEMOGLOBIN ABNORMAL 1 0.0002
261 PLATELET COUNT INCREASED 2 0.0002
262 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
263 PRODUCT PREPARATION ISSUE 1 0.0002
264 SOMNAMBULISM 1 0.0002
265 HYPOGAMMAGLOBULINAEMIA 1 0.0002
266 TOOTH INFECTION 2 0.0002
267 CARDIAC FAILURE ACUTE 1 0.0001
268 ABORTION SPONTANEOUS 6 0.0001
269 ILL-DEFINED DISORDER 9 0.0001
270 ACUTE HEPATIC FAILURE 2 0.0001
271 EYE MOVEMENT DISORDER 1 0.0001
272 ECCHYMOSIS 1 0.0001
273 PERITONITIS 3 0.0001
274 ENCEPHALITIS 1 0.0001
275 LARGE INTESTINE POLYP 1 0.0001
276 HYPERTRANSAMINASAEMIA 1 0.0001
277 HYPOMAGNESAEMIA 2 0.0001
278 HYPONATRAEMIA 8 0.0001
279 HAND FRACTURE 1 0.0001
280 AMNESIA 9 0.0001
281 MOUTH HAEMORRHAGE 1 0.0001
282 CEREBRAL DISORDER 1 0.0001
283 DRUG WITHDRAWAL SYNDROME NEONATAL 2 0.0001
284 PULMONARY MASS 2 0.0001
285 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
286 BRADYCARDIA 7 0.0001
287 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
288 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
289 HYPOALBUMINAEMIA 1 0.0001
290 PELVIC FRACTURE 1 0.0001
291 HAEMORRHAGIC STROKE 1 0.0001
292 DRUG-INDUCED LIVER INJURY 4 0.0001
293 BLOOD ALBUMIN DECREASED 1 0.0001
294 MUSCLE DISORDER 1 0.0001
295 POST PROCEDURAL INFECTION 1 0.0001
296 ASPHYXIA 1 0.0001
297 LIVER INJURY 3 0.0001
298 ENCEPHALOPATHY 3 0.0001
299 RHABDOMYOLYSIS 5 0.0001
300 BLOOD UREA INCREASED 2 0.0001
301 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
302 FACE OEDEMA 2 0.0001
303 VITAMIN D DECREASED 1 0.0001
304 SCAR 2 0.0001
305 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
306 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
307 RESPIRATORY RATE INCREASED 1 0.0001
308 PLATELET COUNT DECREASED 12 0.0001
309 CARDIOTOXICITY 1 0.0001
310 ANAL INCONTINENCE 1 0.0001
311 LIMB INJURY 3 0.0001
312 LIP DRY 1 0.0001
313 LOSS OF CONSCIOUSNESS 14 0.0001
314 BRAIN NEOPLASM 1 0.0001
315 HEPATIC ENCEPHALOPATHY 1 0.0001
316 APPENDICITIS 1 0.0001
317 ATELECTASIS 1 0.0001
318 AUTOIMMUNE DISORDER 1 0.0001
319 PARKINSONISM 1 0.0001
320 BODY TEMPERATURE DECREASED 1 0.0001
321 BRAIN INJURY 1 0.0001
322 EMPHYSEMA 1 0.0001
323 HYPOTHERMIA 1 0.0001
324 TOOTH ABSCESS 1 0.0001
325 MOUTH ULCERATION 2 0.0001
326 SCRATCH 1 0.0001
327 SUDDEN DEATH 1 0.0001
328 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
329 CONFUSIONAL STATE 15 0.0001
330 BLOOD CREATININE INCREASED 6 0.0001
331 OESOPHAGITIS 1 0.0001
332 ASPIRATION 1 0.0001
333 MELAENA 2 0.0001
334 BLOOD PRESSURE DECREASED 6 0.0001
335 NERVE INJURY 1 0.0001
336 RASH MACULO-PAPULAR 2 0.0001
337 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
338 MALNUTRITION 1 0.0001
339 DRUG INTERACTION 14 0.0001
340 HAEMOGLOBIN DECREASED 9 0.0001
341 SHOCK 2 0.0001
342 MUSCLE TWITCHING 2 0.0001
343 SPLENOMEGALY 1 0.0001
344 HYPOXIA 3 0.0001
345 CHOLECYSTITIS 1 0.0001
346 MUSCLE RIGIDITY 1 0.0001
347 CYTOPENIA 1 0.0001
348 PHARYNGITIS 1 0.0001
349 BRAIN OEDEMA 1 0.0001
350 MUSCLE ATROPHY 1 0.0001
351 MYDRIASIS 1 0.0001
352 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
353 SEDATION 2 0.0001
354 JAUNDICE 2 0.0001
355 PNEUMONITIS 2 0.0001
356 IMPAIRED GASTRIC EMPTYING 1 0.0001
357 GINGIVAL BLEEDING 1 0.0001
358 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
359 TOXICITY TO VARIOUS AGENTS 12 0.0001
360 SKIN REACTION 1 0.0001
361 RENAL FAILURE ACUTE 3 0.0001
362 HEART RATE INCREASED 7 0.0001
363 SINUS TACHYCARDIA 1 0.0001
364 ANGINA PECTORIS 2 0.0001
365 CARDIOGENIC SHOCK 1 0.0001
366 HYPOKINESIA 1 0.0001
367 OFF LABEL USE 60 0.0001
368 URINARY INCONTINENCE 2 0.0001
369 HAEMORRHAGE INTRACRANIAL 1 0.0001
370 HEPATIC FAILURE 2 0.0001
371 APHASIA 2 0.0001
372 OSTEOPENIA 1 0.0001
373 DEVICE RELATED INFECTION 1 0.0001
374 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
375 RENAL DISORDER 3 0.0001
376 COGNITIVE DISORDER 3 0.0001
377 CYANOSIS 1 0.0001
378 ARRHYTHMIA 3 0.0001
379 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
380 HALLUCINATION, AUDITORY 1 0.0001
381 HYPOTHYROIDISM 2 0.0001
382 METABOLIC ACIDOSIS 2 0.0001
383 STAPHYLOCOCCAL INFECTION 2 0.0001
384 LIP SWELLING 2 0.0001
385 SKIN DISORDER 2 0.0001
386 URINARY RETENTION 2 0.0001
387 RENAL IMPAIRMENT 5 0.0001
388 CIRCULATORY COLLAPSE 1 0.0001
389 PRODUCT USE ISSUE 11 0.0001
390 MULTI-ORGAN FAILURE 1 0.0001
391 LOCAL SWELLING 1 0.0001
392 HYPERKALAEMIA 2 0.0001
393 GOUT 1 0.0001
394 SOMNOLENCE 11 0.0001
395 HYPERHIDROSIS 7 0.0001
396 ANAPHYLACTIC REACTION 3 0.0001
397 MEDICATION ERROR 3 0.0001
398 BLISTER 3 0.0001
399 DYSARTHRIA 2 0.0001
400 BLOOD SODIUM DECREASED 1 0.0001
401 HYPOCALCAEMIA 1 0.0001
402 CONDITION AGGRAVATED 16 0.0001
403 ANAEMIA 10 0.0001
404 CHOLESTASIS 1 0.0001
405 POST PROCEDURAL COMPLICATION 1 0.0001
406 ACUTE RESPIRATORY FAILURE 1 0.0001
407 PRESCRIBED OVERDOSE 1 0.0001
408 DYSTONIA 1 0.0001
409 NEUTROPENIA 7 0.0001
410 EAR PAIN 1 0.0001
411 CHOKING 1 0.0001
412 DISABILITY 1 0.0001
413 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
414 DISORIENTATION 2 0.0001
415 UPPER LIMB FRACTURE 1 0.0001
416 PREGNANCY 1 0.0000
417 CYTOKINE RELEASE SYNDROME 1 0.0000
418 DYSKINESIA 2 0.0000
419 NEUTROPHIL COUNT DECREASED 2 0.0000
420 BODY TEMPERATURE INCREASED 1 0.0000
421 RIB FRACTURE 1 0.0000
422 PULMONARY HYPERTENSION 1 0.0000
423 ABDOMINAL DISTENSION 5 0.0000
424 CARDIO-RESPIRATORY ARREST 2 0.0000
425 EATING DISORDER 1 0.0000
426 LIVER FUNCTION TEST INCREASED 1 0.0000
427 RECTAL HAEMORRHAGE 2 0.0000
428 PRODUCT PRESCRIBING ISSUE 1 0.0000
429 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
430 FALL 15 0.0000
431 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
432 THROMBOCYTOPENIA 5 0.0000
433 ORAL PAIN 1 0.0000
434 THERAPY NON-RESPONDER 2 0.0000
435 DRUG INEFFECTIVE 58 0.0000
436 PYREXIA 15 0.0000
437 PERICARDIAL EFFUSION 1 0.0000
438 BLOOD CHOLESTEROL INCREASED 2 0.0000
439 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
440 PULMONARY EMBOLISM 4 0.0000
441 PRODUCT PRESCRIBING ERROR 1 0.0000
442 THERAPY INTERRUPTED 3 0.0000
443 DIABETIC KETOACIDOSIS 1 0.0000
444 CEREBRAL INFARCTION 1 0.0000
445 PNEUMONIA 13 0.0000
446 PNEUMONIA ASPIRATION 1 0.0000
447 AGGRESSION 2 0.0000
448 HAEMATEMESIS 1 0.0000
449 HYPOPHAGIA 1 0.0000
450 HEPATITIS 1 0.0000
451 ERYTHEMA 8 0.0000
452 ABDOMINAL PAIN UPPER 8 0.0000
453 ANAPHYLACTIC SHOCK 1 0.0000
454 DIPLOPIA 1 0.0000
455 DEAFNESS 1 0.0000
456 GASTRITIS 1 0.0000
457 CARDIAC FAILURE CONGESTIVE 3 0.0000
458 MENSTRUATION IRREGULAR 1 0.0000
459 BLOOD GLUCOSE INCREASED 7 0.0000
460 BLOOD BILIRUBIN INCREASED 1 0.0000
461 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
462 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
463 OEDEMA 2 0.0000
464 RESPIRATORY ARREST 1 0.0000
465 TREATMENT FAILURE 3 0.0000
466 DIVERTICULITIS 1 0.0000
467 DRUG ABUSE 3 0.0000
468 HERPES ZOSTER 2 0.0000
469 LETHARGY 2 0.0000
470 LIVER FUNCTION TEST ABNORMAL 1 0.0000
471 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
472 TACHYCARDIA 3 0.0000
473 RENAL INJURY 1 0.0000
474 BLOOD POTASSIUM DECREASED 1 0.0000
475 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
476 THERAPEUTIC RESPONSE DECREASED 2 0.0000
477 VERTIGO 2 0.0000
478 ACUTE KIDNEY INJURY 5 0.0000
479 EXPOSURE DURING PREGNANCY 2 0.0000
480 CONSTIPATION 7 0.0000
481 SWELLING 3 0.0000
482 BONE DENSITY DECREASED 1 0.0000
483 CONTUSION 3 0.0000
484 MOVEMENT DISORDER 1 0.0000
485 LACTIC ACIDOSIS 1 0.0000
486 CHOLELITHIASIS 1 0.0000
487 FEBRILE NEUTROPENIA 2 0.0000
488 RENAL FAILURE 4 0.0000
489 VISUAL ACUITY REDUCED 1 0.0000
490 HYPOTENSION 6 0.0000
491 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
492 HAEMATURIA 1 0.0000
493 ILLNESS 3 0.0000
494 MEMORY IMPAIRMENT 4 0.0000
495 INJECTION SITE REACTION 2 0.0000
496 NIGHTMARE 1 0.0000
497 DELIRIUM 1 0.0000
498 NEOPLASM PROGRESSION 1 0.0000
499 RASH MACULAR 1 0.0000
500 CEREBRAL HAEMORRHAGE 1 0.0000
501 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
502 C-REACTIVE PROTEIN INCREASED 1 0.0000
503 DYSURIA 1 0.0000
504 COLITIS 1 0.0000
505 ABNORMAL BEHAVIOUR 1 0.0000
506 CARDIAC FAILURE 2 0.0000
507 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
508 DRY MOUTH 2 0.0000
509 OEDEMA PERIPHERAL 3 0.0000
510 TREMOR 4 0.0000
511 WITHDRAWAL SYNDROME 1 0.0000
512 PRODUCT DOSE OMISSION ISSUE 7 0.0000
513 SKIN EXFOLIATION 2 0.0000
514 URINARY TRACT INFECTION 4 0.0000
515 SEPTIC SHOCK 1 0.0000
516 RASH 10 0.0000
517 PULMONARY OEDEMA 1 0.0000
518 THROAT IRRITATION 1 0.0000
519 NEPHROLITHIASIS 1 0.0000
520 TINNITUS 1 0.0000
521 SKIN DISCOLOURATION 1 0.0000
522 DECREASED APPETITE 5 0.0000
523 CARDIAC DISORDER 2 0.0000
524 DISEASE RECURRENCE 1 0.0000
525 COMA 1 0.0000
526 RASH ERYTHEMATOUS 1 0.0000
527 HYPOGLYCAEMIA 1 0.0000
528 LUNG DISORDER 1 0.0000
529 CHEST DISCOMFORT 2 0.0000
530 PERIPHERAL SWELLING 3 0.0000
531 INFLAMMATION 1 0.0000
532 NERVOUSNESS 1 0.0000
533 MUSCULOSKELETAL PAIN 1 0.0000
534 RASH PRURITIC 1 0.0000
535 ARTHROPATHY 1 0.0000
536 WEIGHT DECREASED 5 0.0000
537 URTICARIA 3 0.0000
538 OXYGEN SATURATION DECREASED 1 0.0000
539 PRODUCT SUBSTITUTION ISSUE 1 0.0000
540 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
541 DYSPHONIA 1 0.0000
542 WHEEZING 1 0.0000
543 CATARACT 1 0.0000
544 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
545 IRRITABILITY 1 0.0000
546 SUICIDE ATTEMPT 1 0.0000
547 PLEURAL EFFUSION 1 0.0000
548 DISCOMFORT 1 0.0000
549 DEATH 14 0.0000
550 DIZZINESS 8 0.0000
551 ASTHENIA 6 0.0000
552 INTENTIONAL OVERDOSE 1 0.0000
553 INFUSION RELATED REACTION 1 0.0000
554 DEHYDRATION 2 0.0000
555 VOMITING 7 0.0000
556 HEPATIC ENZYME INCREASED 1 0.0000
557 COUGH 4 0.0000
558 SLEEP DISORDER 1 0.0000
559 HYPERTENSION 3 0.0000
560 DYSPNOEA 8 0.0000
561 OVERDOSE 3 0.0000
562 HYPOAESTHESIA 2 0.0000
563 DIABETES MELLITUS 1 0.0000
564 INJECTION SITE SWELLING 1 0.0000
565 HOSPITALISATION 2 0.0000
566 PRURITUS 5 0.0000
567 CARDIAC ARREST 1 0.0000
568 COMPLETED SUICIDE 1 0.0000
569 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
570 BALANCE DISORDER 1 0.0000
571 GASTROINTESTINAL DISORDER 1 0.0000
572 MUSCLE SPASMS 2 0.0000
573 CHEST PAIN 2 0.0000
574 DYSPHAGIA 1 0.0000
575 DYSPEPSIA 1 0.0000
576 FLUSHING 1 0.0000
577 DIARRHOEA 6 0.0000
578 FATIGUE 7 0.0000
579 INFLUENZA 1 0.0000
580 ASTHMA 1 0.0000
581 CHILLS 1 0.0000
582 JOINT SWELLING 1 0.0000
583 VISUAL IMPAIRMENT 1 0.0000
584 INSOMNIA 2 0.0000
585 DRY SKIN 1 0.0000
586 PRODUCT QUALITY ISSUE 1 0.0000
587 VISION BLURRED 1 0.0000
588 ANXIETY 2 0.0000
589 INFECTION 1 0.0000
590 MALAISE 3 0.0000
591 PARAESTHESIA 1 0.0000
592 DRUG DEPENDENCE 1 0.0000
593 CEREBROVASCULAR ACCIDENT 1 0.0000
594 MYOCARDIAL INFARCTION 1 0.0000
595 COVID-19 1 0.0000
596 NASOPHARYNGITIS 1 0.0000
597 HYPERSENSITIVITY 1 0.0000
598 ALOPECIA 1 0.0000
599 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
600 PAIN 3 0.0000
601 WEIGHT INCREASED 1 0.0000
602 DEPRESSION 1 0.0000
603 INCORRECT DOSE ADMINISTERED 1 0.0000
604 BACK PAIN 1 0.0000
605 FEELING ABNORMAL 1 0.0000
606 NAUSEA 3 0.0000
607 PAIN IN EXTREMITY 1 0.0000
608 INJECTION SITE PAIN 1 0.0000
609 HEADACHE 2 0.0000